Menopause hormone therapy: what it actually treats, and what it doesn't

Ask a group of women in their late forties or fifties about menopause hormone therapy and the answers will likely span decades of shifting medical advice. Some will recall a mother or older relative warned off it entirely. Others will describe a friend or colleague who swears it changed their life. Doctors say both reactions trace back to the same complicated scientific history, and that the current wave of enthusiasm for the treatment has, in some cases, outpaced what the evidence actually supports.

Menopause hormone therapy, sometimes called MHT or HRT, typically combines estrogen with progesterone, replacing hormones the body stops reliably producing during the menopause transition. It is most consistently effective against the symptoms most directly tied to hormonal decline: hot flashes, night sweats and vaginal dryness. For women experiencing these symptoms, especially in the years immediately around menopause, clinical trial evidence for benefit is strong and well established.

The treatment's reputation was upended in 2002, when a major US study, the Women's Health Initiative, was halted early after data suggested the hormone combination carried increased risks of blood clots, stroke and breast cancer. The findings triggered a sharp, near-universal pullback in prescribing, with millions of women stopping treatment or being advised against starting it, sometimes despite significant quality-of-life symptoms.

A decade later, researchers reanalyzing that same data reached a more nuanced conclusion: the elevated risks applied overwhelmingly to older women who started hormone therapy many years after menopause began, not to women who started treatment closer to the onset of symptoms. This distinction, now widely referred to as the 'timing hypothesis', reshaped clinical guidance and gradually restored physician confidence in prescribing the treatment to women in their late forties and fifties.

That rehabilitation has, in the view of some clinicians, swung too far in the other direction. Menopause has become a heavily discussed topic on social media and in popular culture, and hormone therapy is increasingly framed by some advocates as a near-universal fix, credited with everything from sharper memory and better sleep to protection against heart disease, osteoporosis and even general aging.

Doctors interviewed say the evidence supports some, but not all, of these claims. Hormone therapy does appear to help preserve bone density and can reduce fracture risk, a benefit with reasonably solid trial support. Its effects on mood, cognition and long-term cardiovascular protection are considerably less settled, with some studies showing modest benefit and others showing none, depending heavily on when treatment starts and a patient's individual risk profile.

The risk of disappointment, physicians warn, comes when a patient starts hormone therapy expecting it to resolve every symptom loosely associated with midlife, including fatigue, weight gain, joint pain or low mood that may have other causes entirely. When those symptoms persist despite treatment, some patients conclude the therapy has failed them, when in fact it was never expected to address that particular complaint.

Who should avoid the treatment remains clearer than who should take it. Women with a personal history of breast cancer, certain clotting disorders, or unexplained vaginal bleeding are generally advised against hormone therapy, and doctors stress that any decision should follow an individualized risk assessment rather than a blanket recommendation based on age or symptoms alone.

For women considering the treatment, clinicians recommend starting the conversation with a clear inventory of which specific symptoms are most disruptive, since that shapes both the likelihood of benefit and the choice of formulation, dose and delivery method, which range from pills to patches to vaginal preparations targeting local symptoms specifically.

The broader lesson, according to menopause specialists, is that hormone therapy is a genuinely effective treatment for a defined set of symptoms rather than a cure-all for the menopause transition as a whole, and that getting the most benefit from it depends on matching expectations to what the underlying evidence, not social media testimonials, actually shows.